Pharmaceutical Industry

Page 40 of 100

Sarepta Stock Roche Deal
Health

Controversial Biotech Sarepta Keeps Up Unlikely Win Streak With $1.15 Billion Roche Deal

By
December 23, 2019
Big Pharma ROI
Newsletters

Big Pharma’s Return on Investment Plummets to a Dismal 10-Year Low

By
December 18, 2019
Multiple myeloma MMRF
Newsletters

GlaxoSmithKline Hopes to Take on Rivals With Rare Blood Cancer Drug

By
December 18, 2019
Michigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors
Health

Michigan Uses Drug Trafficking Law to Sue Walgreens and Other Opioid Distributors

By David Eggert and The Associated Press
December 17, 2019
Drugs and Tech Revolutionizinf Healthcare
Health

The 4 Most Game-Changing Medical Advances of the Past Decade

By
December 17, 2019
Duchenne Sarepta FDA
Newsletters

FDA Approves Sarepta Duchenne Drug in Stunning Reversal

By
December 14, 2019
New British Chief Executive Officer of French pharmaceutical group Sanofi Paul Hudson talks to journalists at Sanofi headquarters in Paris on October 1, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
International

Why Sanofi’s New CEO Is Trading Diabetes Drugs for Cancer Breakthroughs

By James Paton and Bloomberg
December 10, 2019
Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology
Health

Cancer Drug Company Acquisitions Showcase Pharma Giants Big Push Into Oncology

By Riley Griffin, James Paton and Bloomberg
December 9, 2019
Paul Hudson, chief executive officer of Sanofi, gestures as he speaks during a panel session on the sidelines of the China International Import Expo (CIIE) in Shanghai, China, on Tuesday, Nov. 5, 2019. The CIIE -- now in its second year -- is designed to showcase the countrys desire to shift its economy toward consumption by buying more foreign goods. Photographer: Qilai Shen/Bloomberg via Getty Images
International

Why Sanofi Is Buying a U.S. Cancer Biotech for Nearly 3 Times Its Market Value

By James Paton and Bloomberg
December 9, 2019
Sanofi’s New CEO Readies Rx Plan For Pharma Giant
Leadership

Sanofi’s New CEO Readies Rx Plan For Pharma Giant

By
December 9, 2019
Biogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’
Leadership

Biogen CEO on Controversial Alzheimer’s Drug: ‘There Is Hope’

By
December 6, 2019
Biogen Alzheimers Drug Data
Newsletters

The Broader Implications of Biogen’s Divisive Alzheimer’s Drug

By
December 5, 2019
Diabetes medicine pills
Health

FDA Is Testing Diabetes Drug Metformin for NDMA, a Carcinogen

By John Lauerman and Bloomberg
December 4, 2019
Astellas Gene Therapy Deal
Newsletters

The Gene Therapy Spree Rolls on With $3 Billion Astellas Deal

By
December 3, 2019
Biogen Stock Alzheimer's Aducanumab
Newsletters

Biogen Stock Falls After Analyst Throws Cold Water on Its Alzheimer’s Drug Bet

By
December 2, 2019

Most Popular